Universe Pharmaceuticals (UPC) Finished Goods: 2021-2024
- Universe Pharmaceuticals' Finished Goods fell 58.90% to $1.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.1 million, marking a year-over-year decrease of 58.90%. This contributed to the annual value of $1.1 million for FY2024, which is 58.90% down from last year.
- As of Q3 2024, Universe Pharmaceuticals' Finished Goods stood at $1.1 million, which was down 58.90% from $2.8 million recorded in Q3 2023.
- In the past 5 years, Universe Pharmaceuticals' Finished Goods registered a high of $2.8 million during Q3 2023, and its lowest value of $1.1 million during Q3 2024.
- Over the past 3 years, Universe Pharmaceuticals' median Finished Goods value was $1.3 million (recorded in 2022), while the average stood at $1.8 million.
- In the last 5 years, Universe Pharmaceuticals' Finished Goods spiked by 107.64% in 2023 and then slumped by 58.90% in 2024.
- Universe Pharmaceuticals' Finished Goods (Quarterly) stood at $2.0 million in 2021, then crashed by 32.14% to $1.3 million in 2022, then spiked by 107.64% to $2.8 million in 2023, then tumbled by 58.90% to $1.1 million in 2024.
- Its last three reported values are $1.1 million in Q3 2024, $2.8 million for Q3 2023, and $1.3 million during Q3 2022.
